Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OSTEOPOROSIS, POSTMENOPAUSAL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02058420
What this trial is testing

Tocotrienols and Bone Health of Postmenopausal Women

Who this might be right for
Osteoporosis
Texas Tech University Health Sciences Center 78
Not applicableStudy completedNCT01501344
What this trial is testing

Open-label Study to Evaluate the Effect of MBP-80 on Bone Remodelling

Who this might be right for
Postmenopausal Osteoporosis
Groupe De Recherche En Rhumatologie Et Maladies Osseuses Inc. 50
Post-approval studies (Phase 4)Study completedNCT02598440
What this trial is testing

Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Hoffmann-La Roche 341
Post-approval studies (Phase 4)UnknownNCT02389179
What this trial is testing

Determination of Vitamin D Dose to Maintain Sufficiency Amongst Indian and Malay Women in the Tropics

Who this might be right for
Vitamin D Deficiency
Sharifah Faradila bt Wan Muhamad Hatta 150
Large-scale testing (Phase 3)Study completedNCT04729621
What this trial is testing

Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Teva Pharmaceuticals USA 332
Early research (Phase 1)Study completedNCT00577850
What this trial is testing

Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose

Who this might be right for
OsteopeniaOsteoporosis
Warner Chilcott 32
Not applicableStudy completedNCT01397955
What this trial is testing

Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

Who this might be right for
Osteoporosis, Postmenopausal
Bayer 148
Early research (Phase 1)Study completedNCT00540878
What this trial is testing

Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women

Who this might be right for
Osteoporosis
GlaxoSmithKline 25
Post-approval studies (Phase 4)Active Not RecruitingNCT03623633
What this trial is testing

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

Who this might be right for
Osteoporosis, PostmenopausalOsteoporosis
Massachusetts General Hospital 51
Not applicableStudy completedNCT00936260
What this trial is testing

Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis
Ciudad Universitaria, Spain 228
Not applicableStudy completedNCT02271204
What this trial is testing

Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis
Clinic of Endocrinology and Metabolic Disorders, Macedonia 700
Post-approval studies (Phase 4)Study completedNCT02176382
What this trial is testing

Denosumab and Teriparatide Study (DATA-HD and DATA-EX)

Who this might be right for
Postmenopausal Osteoporosis
Massachusetts General Hospital 76
Large-scale testing (Phase 3)Study completedNCT00150969
What this trial is testing

Vitamin K Supplementation in Post-Menopausal Osteopenia

Who this might be right for
Post-Menopausal OsteoporosisPost-Menopausal Osteopenia
University Health Network, Toronto 440
Not applicableStudy completedNCT05650437
What this trial is testing

Impact of Ultraviolet Radiation on Bone Density and Muscle Strength in Postmenopausal Women

Who this might be right for
Postmenopausal Osteoporosis
Cairo University 70
Early research (Phase 1)UnknownNCT03475719
What this trial is testing

A Clinical Trial to Evaluate the Safety and Pharmacokinetic

Who this might be right for
Osteoporosis, Postmenopausal
Huons Co., Ltd. 52
Not applicableStudy completedNCT00436917
What this trial is testing

Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer

Who this might be right for
Breast CancerOsteoporosis
Mayo Clinic 60
Not applicableStudy completedNCT01757340
What this trial is testing

Calorie Restriction With Leucine Supplementation

Who this might be right for
ObesityMenopauseOsteoporosis+1 more
Washington University School of Medicine 43
Not applicableStudy completedNCT04206618
What this trial is testing

Circulating Myokine Levels and Bone Metabolism

Who this might be right for
Osteoporosis, Postmenopausal
424 General Military Hospital 220
Not applicableStudy completedNCT04873960
What this trial is testing

Translation and Cross -Cultural Validation of ECOS-16 Questionnaire in Urdu Language

Who this might be right for
Postmenopausal OsteopeniaQuality of LifeValidity+2 more
Riphah International University 80
Post-approval studies (Phase 4)Study completedNCT04609189
What this trial is testing

Pearlium®/Effecti-Cal®, a Novel Formulation of Calcium, Vitamin D and Minerals for Prevention of Postmenopausal Bone Loss

Who this might be right for
Osteoporosis, Postmenopausal
University of Alberta 97
Next Page